Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 190


HPV genotype prevalence in Australian women undergoing routine cervical screening by cytology status prior to implementation of an HPV vaccination program.

Tabrizi SN, Brotherton JM, Stevens MP, Condon JR, McIntyre P, Smith D, Garland SM; WHINURS group.

J Clin Virol. 2014 Jul;60(3):250-6. doi: 10.1016/j.jcv.2014.04.013. Epub 2014 May 5.


Prevalence of human papillomavirus in young Italian women with normal cytology: how should we adapt the national vaccination policy?

Panatto D, Amicizia D, Tanzi E, Bianchi S, Frati ER, Zotti CM, Lai PL, Bechini A, Rossi S, Gasparini R.

BMC Infect Dis. 2013 Dec 6;13:575. doi: 10.1186/1471-2334-13-575.


Prevalence of type-specific human papillomavirus infection among women in France: Implications for screening, vaccination, and a future generation of multivalent HPV vaccines.

Monsonego J, Zerat L, Syrjänen K, Zerat JC, Smith JS, Halfon P.

Vaccine. 2012 Jul 27;30(35):5215-21. doi: 10.1016/j.vaccine.2012.06.013. Epub 2012 Jun 17.


Age and geographic variability of human papillomavirus high-risk genotype distribution in a large unvaccinated population and of vaccination impact on HPV prevalence.

Carozzi F, De Marco L, Gillio-Tos A, Del Mistro A, Girlando S, Baboci L, Trevisan M, Burroni E, Grasso S, Giorgi Rossi P, Ronco G; NTCC Working Group.

J Clin Virol. 2014 Jul;60(3):257-63. doi: 10.1016/j.jcv.2014.04.009. Epub 2014 Apr 18.


Assessment of herd immunity and cross-protection after a human papillomavirus vaccination programme in Australia: a repeat cross-sectional study.

Tabrizi SN, Brotherton JM, Kaldor JM, Skinner SR, Liu B, Bateson D, McNamee K, Garefalakis M, Phillips S, Cummins E, Malloy M, Garland SM.

Lancet Infect Dis. 2014 Oct;14(10):958-66. doi: 10.1016/S1473-3099(14)70841-2. Epub 2014 Aug 5.


Human papillomavirus prevalence among indigenous and non-indigenous Australian women prior to a national HPV vaccination program.

Garland SM, Brotherton JM, Condon JR, McIntyre PB, Stevens MP, Smith DW, Tabrizi SN; WHINURS study group.

BMC Med. 2011 Sep 13;9:104. doi: 10.1186/1741-7015-9-104.


Pre-vaccination prevalence of infections with 25 non-high-risk human papillomavirus types among 1,000 Slovenian women in cervical cancer screening.

Učakar V, Poljak M, Oštrbenk A, Klavs I.

J Med Virol. 2014 Oct;86(10):1772-9. doi: 10.1002/jmv.23997. Epub 2014 Jun 30.


Prevalence of type-specific HPV infection by age and grade of cervical cytology: data from the ARTISTIC trial.

Sargent A, Bailey A, Almonte M, Turner A, Thomson C, Peto J, Desai M, Mather J, Moss S, Roberts C, Kitchener HC; ARTISTIC Study Group.

Br J Cancer. 2008 May 20;98(10):1704-9. doi: 10.1038/sj.bjc.6604324. Epub 2008 Apr 8.


Human papillomavirus-type distribution in women with and without cervical neoplasia in north India.

Bhatla N, Dar L, Rajkumar Patro A, Kumar P, Pati SK, Kriplani A, Gulati A, Broor S, Iyer VK, Mathur S, Shah KV, Gravitt PE.

Int J Gynecol Pathol. 2008 Jul;27(3):426-30. doi: 10.1097/PGP.0b013e31816085ba.


Type- and age-specific distribution of human papillomavirus in women attending cervical cancer screening in Finland.

Leinonen MK, Anttila A, Malila N, Dillner J, Forslund O, Nieminen P.

Br J Cancer. 2013 Nov 26;109(11):2941-50. doi: 10.1038/bjc.2013.647. Epub 2013 Oct 17.


Human papillomavirus prevalence, viral load and pre-cancerous lesions of the cervix in women initiating highly active antiretroviral therapy in South Africa: a cross-sectional study.

Moodley JR, Constant D, Hoffman M, Salimo A, Allan B, Rybicki E, Hitzeroth I, Williamson AL.

BMC Cancer. 2009 Aug 7;9:275. doi: 10.1186/1471-2407-9-275.


Prevalence of human papillomavirus genotypes among women in Hunan province, China.

Li H, Zhang J, Chen Z, Zhou B, Tan Y.

Eur J Obstet Gynecol Reprod Biol. 2013 Sep;170(1):202-5. doi: 10.1016/j.ejogrb.2013.05.010. Epub 2013 Jun 18.


Determination of the diagnostic accuracy of testing for high-risk (HR) human papillomavirus (HPV) types 16, 18 and 45 in precancerous cervical lesions: preliminary data.

Tiews S, Steinberg W, Schneider W, Hanrath C.

J Clin Virol. 2009 Nov;46 Suppl 3:S11-5. doi: 10.1016/S1386-6532(09)70295-1.


HPV prevalence and genotype distribution in a population-based split-sample study of well-screened women using CLART HPV2 human papillomavirus genotype microarray system.

Bonde J, Rebolj M, Ejegod DM, Preisler S, Lynge E, Rygaard C.

BMC Infect Dis. 2014 Jul 26;14:413. doi: 10.1186/1471-2334-14-413.


Prevalence of high-risk human papillomavirus type 16/18 infection among women with normal cytology: risk factor analysis and implications for screening and prophylaxis.

Gupta S, Sodhani P, Sharma A, Sharma JK, Halder K, Charchra KL, Sardana S, Singh V, Sehgal A, Das BC.

Cytopathology. 2009 Aug;20(4):249-55. doi: 10.1111/j.1365-2303.2008.00611.x. Epub 2008 Oct 24.


Prevalence of type-specific HPV infection in Uruguay.

Berois N, Heard I, Fort Z, Alonso R, Sica A, Moerzinger P, Rodriguez G, Sancho-Garnier H, Osinaga E, Favre M.

J Med Virol. 2014 Apr;86(4):647-52. doi: 10.1002/jmv.23870. Epub 2013 Dec 30.


Prevalence of human papillomavirus infection among women with and without normal cervical histology in Shandong Province, China.

Yuan X, Yang Y, Gu D, Liu H, Yang H, Wang M.

Arch Gynecol Obstet. 2011 Jun;283(6):1385-9. doi: 10.1007/s00404-010-1584-0. Epub 2010 Jul 14.


Human papillomavirus types distribution in organised cervical cancer screening in France.

Heard I, Tondeur L, Arowas L, Falguières M, Demazoin MC, Favre M.

PLoS One. 2013 Nov 14;8(11):e79372. doi: 10.1371/journal.pone.0079372. eCollection 2013.


[Prevalence of genotype-specific HPV infection among women in France: implications for screening and vaccination].

Monsonego J, Zerat L, Syrjänen K, Zerat JC, Smith JS, Halfon P.

Gynecol Obstet Fertil. 2013 May;41(5):305-13. doi: 10.1016/j.gyobfe.2013.03.003. Epub 2013 May 3. French.

Items per page

Supplemental Content

Write to the Help Desk